Jackson Creek Investment Advisors LLC Grows Stock Holdings in Encompass Health Co. (NYSE:EHC)

Jackson Creek Investment Advisors LLC boosted its holdings in Encompass Health Co. (NYSE:EHC - Free Report) by 364.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 13,910 shares of the company's stock after acquiring an additional 10,915 shares during the quarter. Jackson Creek Investment Advisors LLC's holdings in Encompass Health were worth $928,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. Gilliland Jeter Wealth Management LLC bought a new position in Encompass Health in the 4th quarter valued at about $269,000. Headlands Technologies LLC bought a new position in shares of Encompass Health during the 4th quarter worth approximately $70,000. GAMMA Investing LLC bought a new position in shares of Encompass Health during the 4th quarter worth approximately $33,000. Linden Thomas Advisory Services LLC lifted its position in shares of Encompass Health by 1.7% during the 4th quarter. Linden Thomas Advisory Services LLC now owns 15,473 shares of the company's stock worth $1,032,000 after buying an additional 253 shares in the last quarter. Finally, California Public Employees Retirement System lifted its position in shares of Encompass Health by 160.5% during the 4th quarter. California Public Employees Retirement System now owns 515,717 shares of the company's stock worth $34,409,000 after buying an additional 317,730 shares in the last quarter. Institutional investors own 97.25% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. William Blair reissued an "outperform" rating on shares of Encompass Health in a research report on Wednesday, February 7th. Truist Financial lifted their target price on shares of Encompass Health from $82.00 to $86.00 and gave the stock a "buy" rating in a research report on Friday, February 9th. Stephens reissued an "overweight" rating and set a $85.00 target price on shares of Encompass Health in a research report on Tuesday, January 16th. Mizuho lifted their price target on shares of Encompass Health from $93.00 to $95.00 and gave the stock a "buy" rating in a report on Thursday, April 25th. Finally, Barclays lifted their price target on shares of Encompass Health from $101.00 to $108.00 and gave the stock an "overweight" rating in a report on Thursday, April 25th. Eight investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, Encompass Health currently has an average rating of "Buy" and a consensus target price of $88.13.

Insider Transactions at Encompass Health

In other news, CEO Mark J. Tarr sold 44,976 shares of the company's stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $83.27, for a total value of $3,745,151.52. Following the transaction, the chief executive officer now owns 554,098 shares of the company's stock, valued at $46,139,740.46. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 2.10% of the company's stock.

Encompass Health Stock Performance

Encompass Health stock traded down $0.54 during mid-day trading on Wednesday, reaching $82.84. The company's stock had a trading volume of 543,838 shares, compared to its average volume of 670,891. Encompass Health Co. has a 12-month low of $57.55 and a 12-month high of $85.84. The company has a market capitalization of $8.30 billion, a P/E ratio of 22.39, a PEG ratio of 1.31 and a beta of 0.94. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.28 and a current ratio of 1.37. The firm's fifty day moving average price is $78.64 and its two-hundred day moving average price is $71.25.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings data on Wednesday, April 24th. The company reported $1.12 earnings per share for the quarter, beating analysts' consensus estimates of $0.93 by $0.19. Encompass Health had a net margin of 7.60% and a return on equity of 18.01%. The business had revenue of $1.32 billion during the quarter, compared to analyst estimates of $1.27 billion. During the same period in the previous year, the business earned $0.88 EPS. Encompass Health's revenue was up 13.4% compared to the same quarter last year. Sell-side analysts predict that Encompass Health Co. will post 4.1 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were given a dividend of $0.15 per share. The ex-dividend date was Thursday, March 28th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.72%. Encompass Health's dividend payout ratio (DPR) is currently 16.22%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.